Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients?
- PMID: 30819668
- PMCID: PMC6419283
- DOI: 10.2215/CJN.00960119
Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients?
Keywords: Drugs; Economic Impact; Generic; Immunosuppressive Agents; Transplant Recipients; immunosuppression; kidney transplantation.
Comment on
-
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.Clin J Am Soc Nephrol. 2019 Mar 7;14(3):421-430. doi: 10.2215/CJN.10590918. Epub 2019 Feb 28. Clin J Am Soc Nephrol. 2019. PMID: 30819667 Free PMC article.
References
-
- Centers for Medicare & Medicaid Services: Medicare Coverage of Kidney Dialysis & Kidney Transplant Services, 2018. Available at: https://www.medicare.gov/pubs/pdf/10128-medicare-coverage-esrd.pdf. Accessed January 21, 2019
-
- United States Renal Data System : 2018 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018
-
- Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC: Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 77: 769–776, 2004 - PubMed
-
- Gill JS, Tonelli M: Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation. N Engl J Med 366: 586–589, 2012 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
